Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:809382.
doi: 10.1155/2013/809382. Epub 2013 Dec 30.

Prognosis of multifocal papillary thyroid carcinoma

Sheng-Fong Kuo  1 , Shu-Fu Lin  1 , Tzu-Chieh Chao  2 , Chuen Hsueh  3 , Kun-Ju Lin  4 , Jen-Der Lin  1
Affiliations

Prognosis of multifocal papillary thyroid carcinoma

Sheng-Fong Kuo et al. Int J Endocrinol. 2013.

Abstract

This study was to investigate the clinical features and therapeutic outcomes of multifocal papillary thyroid microcarcinoma (PTMC). A total of 2,418 papillary thyroid carcinoma (PTC) patients had undergone thyroidectomy in one medical center between 1977 and 2010. There were 483 (20.0%) diagnosed with multifocal PTC. The percentage of multifocal PTC was higher in PTMC patients (22.0%) than in non-PTMC patients (19.5%). Demographic and clinical characteristics of PTMC and multifocal PTC in PTC patients were traced. Multifocal PTC patients presented with smaller tumors at an older age, and a higher percentage underwent total or complete thyroidectomy. These patients also showed a higher incidence of postoperative disease progression than did unifocal PTC patients. Comparison of 483 patients with multifocal PTMC and non-PTMC tumors showed a higher incidence of postoperative disease progression in patients with non-PTMC; otherwise, there was no statistical difference in disease-specific and total mortality between these two groups. In conclusion, the incidence of multifocal PTMC was not lower than that of non-PTMC, and postoperative therapies were necessary for both multifocal PTMC and non-PTMC patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of papillary thyroid carcinoma (PTC) patients and percentage of papillary thyroid microcarcinoma and multifocal PTC during different periods.
Figure 2
Figure 2
Cancer-specific survival curves (a) and progression-free rates (b) for multifocal papillary microcarcinoma and non-PTMC groups.
See this image and copyright information in PMC

References

    1. Cramer JD, Fu P, Harth KC, Margevicius S, Wilhelm SM. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry. Surgery. 2010;148(6):1147–1152. - PubMed
    1. Londero SC, Krogdahl A, Bastholt L, et al. Papillary thyroid carcinoma in Denmark 1996–2008: an investigation of changes in incidence. Cancer Epidemiology. 2013;37(1):e1–e6. - PubMed
    1. Kuo S-F, Chao T-C, Chang H-Y, Hsueh C, Yang C-H, Lin J-D. Prognostic evaluation of patients with multicentric papillary thyroid microcarcinoma. Journal of the Formosan Medical Association. 2011;110(8):511–517. - PubMed
    1. Ivanova R, Soares P, Castro P, Sobrinho-Simões M. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Archiv. 2002;440(4):418–424. - PubMed
    1. Giannini R, Ugolini C, Lupi C, et al. The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 2007;92(9):3511–3516. - PubMed

LinkOut - more resources